SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Celldex Therapeutics, Inc. (CLDX)

CLDX RSS Feed
Add CLDX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/13/2017 7:52:49 PM - Followers: 99 - Board type: Free - Posts Today: 0

 

 

 Celldex Therapeutics, Inc. (CLDX)

 

slider-images-2

 slider-images-3
http://www.celldextherapeutics.com
 

 

 
Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
 
CIK
0000744218
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
 
Management: 
http://www.celldextherapeutics.com/about/management.php
 
 
Product Pipeline: 
http://www.celldextherapeutics.com/pipeline/pipeline-overview.php
 
 
News and Press Releases: 
http://ir.celldextherapeutics.com/releases.cfm
 
http://finance.yahoo.com/q/h?s=CLDX+Headlines

 

November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
 
 
Events and Presentations:
http://ir.celldextherapeutics.com/events.cfm
 
 
SEC Filings:
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000744218&owner=exclude&count=40
 
 
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
 
 
Share Structure:
See SEC filings
 
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications
ir@celldextherapeutics.com


----------------------------------------------

November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
 

yes November 8, 2016  yes

 



http://www.fool.com/investing/2016/11/07/premium-celldex-therapeutics-inc-q3-results.aspx?source=djc&utm_campaign=article&utm_medium=feed&utm_source=djc


From a financial standpoint, the biggest update from Celldex related to its cash position. The biotech reported cash, cash equivalents, and marketable securities totaling $203.2 million at the end of the third quarter. Celldex used $24 million in cash during the quarter. 

yesyesyesyesyesyesyesyesyesyesyesyesyesyes



--------------------------------------------
 

 
 

 

  


 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

 

SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
CLDX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CLDX News: Current Report Filing (8-k) 09/12/2017 04:06:56 PM
CLDX News: Celldex Announces Departure of Chief Medical Officer 09/12/2017 04:01:00 PM
CLDX News: Statement of Changes in Beneficial Ownership (4) 09/05/2017 08:18:52 AM
CLDX News: Celldex Announces Completion of Enrollment in Phase 2b Study of Glembatumumab Vedotin in Triple Negative Breast Cancer 08/23/2017 09:15:00 AM
CLDX News: Securities Registration: Employee Benefit Plan (s-8) 08/10/2017 04:07:50 PM
PostSubject
#1444   wow a huge buy held back! institutional purchase, harry crumb 09/13/17 07:52:49 PM
#1443   How about now? 2014shelby 09/12/17 05:46:21 PM
#1442   huge upside may happen on positive catalysts, more harry crumb 09/12/17 10:10:21 AM
#1441   Good. $5+ coming? 2014shelby 09/11/17 09:52:05 PM
#1440   cldx needs to be outgoing with some news harry crumb 09/09/17 03:27:57 PM
#1439   all the gains gone, pump an dump by harry crumb 09/08/17 11:50:04 AM
#1438   Thanks. You seem to be on top of 2014shelby 09/07/17 12:45:59 PM
#1437   im thinking mutual fund purchases, before news hits. harry crumb 09/07/17 12:36:57 PM
#1436   Yes. Any thoughts on why? 2014shelby 09/07/17 12:30:30 PM
#1435   spike! !!! harry crumb 09/07/17 11:55:37 AM
#1434   gotcha harry crumb 08/31/17 07:57:37 PM
#1433   I agree maybe higher, but That will be fwb 08/31/17 05:57:42 PM
#1432   straight to 15 on supported news of a harry crumb 08/31/17 05:17:52 PM
#1431   Slow walk up to $3.00 fwb 08/31/17 11:54:07 AM
#1430   look for cldx to add market value over harry crumb 08/30/17 08:56:04 AM
#1429   That's a major drop given that CLDX is 2014shelby 08/19/17 05:31:31 PM
#1428   agree, the pipeline is robust at that, theres harry crumb 08/18/17 10:45:53 PM
#1427   Yeah, I wouldn't expect much movement until we trebeg 08/08/17 03:25:12 PM
#1426   Simply a pre earnings bump...likely move in one ConstitutionNow 08/08/17 11:52:25 AM
#1425   Why's CLDX moving up or is this a 2014shelby 08/08/17 10:22:38 AM
#1423   take a hike traderclay! harry crumb 08/04/17 09:40:35 PM
#1422   * * $CLDX Video Chart 08-01-17 * * ClayTrader 08/01/17 05:19:38 PM
#1421   30 minute Technicals looking very good for a ConstitutionNow 07/25/17 05:54:17 PM
#1419   I think I may be flipping some and 2014shelby 06/25/17 12:14:10 PM
#1418   Yeah, $4 would be good at this point trebeg 06/25/17 12:10:25 PM
#1417   Good point. How about just $4 first? CLDX 2014shelby 06/23/17 09:35:41 PM
#1416   Harry...I would love to see your scenario play trebeg 06/23/17 06:49:52 PM
#1415   all the insiders are buying up shares as harry crumb 06/22/17 11:54:46 PM
#1414   Will CLDX ever hit $4 again? 2014shelby 06/22/17 06:46:16 PM
#1413   there will be massive covering coming if their harry crumb 06/21/17 10:24:55 AM
#1412   liking the new trend its forming. good chance harry crumb 06/19/17 09:25:35 PM
#1411   added more, go cldx! harry crumb 06/16/17 02:01:39 PM
#1410   back up, timing is everything. hopefully they got harry crumb 06/08/17 01:01:22 PM
#1409   Geeez, where's the bottom. Bought some @ 2.38 Hard Locke1 06/07/17 03:46:14 PM
#1408   covered boxed short position, let it go up harry crumb 06/07/17 08:41:09 AM
#1407   This was like $30 at one time. Hope noretreat 06/06/17 07:46:05 PM
#1406   That failure in glio trial did CLDX no north40000 06/06/17 06:39:54 PM
#1405   lets hope they nail the science, this was harry crumb 06/06/17 04:22:23 PM
#1404   Buying shares and never letting go. When this REDEMPTIVE 06/06/17 02:37:09 PM
#1403   adding shares here on the dip, they are harry crumb 06/06/17 12:49:21 PM
#1402   What we have here is a typical sell REDEMPTIVE 06/06/17 11:40:34 AM
#1401   New 52 week lows....painful to watch. Locke1 06/06/17 11:07:13 AM
#1400   Thanks for your opinion, I tend to agree. Locke1 06/06/17 06:21:23 AM
#1399   Locke1, I don't see a mistake here as trebeg 06/06/17 02:56:10 AM
#1398   It seems latest information given was not well Locke1 06/05/17 10:44:43 PM
#1397   mayb, hearing theres excitement coming harry crumb 06/01/17 10:03:56 AM
#1396   Im in at 2.83, hoping we get a ConstitutionNow 05/31/17 10:56:49 PM
#1395   sector harry crumb 05/31/17 02:56:57 PM
#1394   Not looking that way today?? What's driving it REDEMPTIVE 05/31/17 10:38:35 AM
#1393   going to get interesting here with cldx with harry crumb 05/28/17 08:41:30 AM
PostSubject